ArticleFrontiers in immunology2021

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.

Masaud Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.